Kymera Therapeutics, Inc. (KYMR)
NASDAQ·Healthcare·Biotechnology
$105.46
-0.66%
Mkt Cap $9.05B
Analyst Ratings
Buy
12
Hold
0
Sell
0
Price Target (61 analysts)
$125.29
Range $97.00 – $155.00
Implied Upside
+18.8%
Consensus $125.29 vs current $105.46
NASDAQ·Healthcare·Biotechnology
$105.46
-0.66%
Mkt Cap $9.05B
Buy
12
Hold
0
Sell
0
Price Target (61 analysts)
$125.29
Range $97.00 – $155.00
+18.8%
Consensus $125.29 vs current $105.46